Concepedia

Chloe Ran Tu

CR

Statistics

Publications

6

Citations

356

H-Index

6

Active since

2022

Affiliations

University of Hong Kong(Current)

University of California, Los Angeles

Chinese University of Hong Kong

Dana-Farber Cancer Institute

Dana-Farber Brigham Cancer Center

Chloe Ran Tu is an author at University of Hong Kong specializing in oncology, cancer immunology, and cancer immunotherapy.

Publications per year

2022–2025

6

Publications

6

A neoantigen vaccine generates antitumour immunity in renal cell carcinoma

David A. Braun, Giorgia Moranzoni, Vipheaviny Chea et al. · Nature · 2025 · 165 citations · Full text

Medicine, Immunology, Oncology +17

Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironment

Xiwei Wang, Yanmei Zhang, Xiaofeng Mu et al. · Journal for ImmunoTherapy of Cancer · 2022 · 60 citations · Full text

Medicine, Cancer Biology, Oncology +17

Glucose metabolism controls human γδ T-cell-mediated tumor immunosurveillance in diabetes

Xiaofeng Mu, Zheng Xiang, Yan Xu et al. · Cellular and Molecular Immunology · 2022 · 51 citations · Full text

Medicine, Immunology, Oncology +14

Tumor vaccine based on extracellular vesicles derived from γδ‐T cells exerts dual antitumor activities

Xiwei Wang, Yanmei Zhang, Yuet Chung et al. · Journal of Extracellular Vesicles · 2023 · 35 citations · Full text

Life Sciences, Immunology, Oncology +17

A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma

Eryn Blass, Derin B. Keskin, Chloe Ran Tu et al. · Cell · 2025 · 30 citations · Full text

Medicine, Immunology, Oncology +14

1–5 of 6